The Wellness Industry Is Just Soda With Better Branding
Share
Exposing detoxes, miracle powders, and influencer biohacks that distract from fundamentals. How the modern wellness industry mimics the marketing playbook of legacy food companies, shifting focus away from foundational, free wellness practices.
There is a $6 can of sparkling water on the counter. It is sage green. The font is a restrained serif. The label lists ashwagandha, lion's mane, and something called "adaptogenic botanical extract," which is not a regulated term and does not need to be, because the product is not a drug. It is a beverage. It is, stripped of its packaging decisions, carbonated water with trace quantities of herbal compounds at doses too small to demonstrate clinical effect, sweetened with monk fruit, and priced at a point that implies someone with a laboratory coat was involved in its creation.
No one with a laboratory coat was involved in its creation.
Welcome to the wellness industry, which has achieved something the original processed food companies, for all their considerable marketing genius, never quite managed: it has convinced a significant portion of its customers that consumption is the same thing as care. That spending is the same thing as health. That the ritual of the morning supplement stack, the adaptogenic latte, the greens powder dissolved in water that tastes faintly of cut grass and good intentions — that these things are not indulgences dressed as medicine, but medicine itself. The soda fountain always knew it was selling you a treat. The wellness aisle has convinced itself, and you, that it is selling you something more serious than that. This conviction is worth examining, because it is costing people — in money, in attention, and in the compounding opportunity cost of habits never built — considerably more than the price on the label.
The Oldest Playbook
In 1953, a Coca-Cola advertisement promised energy, refreshment, and the specific shimmer of a life being lived correctly. The drink was mostly water, mostly sugar, and entirely a mood sold back to the consumer at a markup. The advertisement did not mention the sugar. It mentioned vitality. It mentioned the bright-eyed woman in the sundress, the sweating bottle, the social belonging of the shared moment. The product was the prop. The fantasy was the product.
Seventy years later, the bottle has gone matte, the sugar has become monk fruit, the sundress has become linen, and the bright-eyed woman has her eyes closed — not from pleasure, but from the inward-focused serenity of someone who has, through disciplined consumption, achieved a state of optimization the rest of us are still working toward. The fantasy has been updated. The mechanism is identical.
What changed is not the underlying transaction but its emotional register. The soda companies sold happiness — uncomplicated, outward-facing, democratic. The wellness industry sells something more intimate and more durable: the management of anxiety. Specifically, the anxiety of a health-literate, information-saturated consumer who knows enough about cortisol and gut microbiomes and mitochondrial function to be worried, but not quite enough to evaluate the products that have organized themselves around that worry. This consumer is not naive. They read labels. They listen to podcasts. They have opinions about seed oils. The industry has been built, with extraordinary precision, for exactly them.
What This Article Is
This is not an argument against caring about your health. It is an argument that the wellness industry, in its current form, has systematically misdirected that care — toward expensive, inadequately evidenced products and away from the free, physiologically substantiated fundamentals that the peer-reviewed literature has identified, consistently and without much drama, as the primary drivers of human health and longevity. Sleep. Water. Movement. Whole food. Social connection. These are not insufficiently sophisticated answers to the question of how to be healthy. They are the answers. The industry's central commercial problem is that they cannot be sold, and it has resolved that problem by making them feel inadequate — by surrounding them with a paid ecosystem so dense that the free things become invisible, or preliminary, or quaint.
What follows is an examination of how that happened: the marketing mechanics borrowed from legacy food companies, the pseudoscience assembled to justify premium price points, the specific pillars — detox culture, supplement mythology, influencer biohacking — on which the edifice rests, and the real cost, physiological and otherwise, of the attention the industry has successfully redirected away from the boring things that work.
The boring things work. They have always worked. Someone has simply been making a great deal of money ensuring that you are not entirely sure of this.
That is where we begin.
I. The New Soda Fountain
Picture the advertisement: a sweating glass bottle, crimson and white, cradled in the hands of a bright-eyed woman in a sundress. Coca-Cola refreshes you best! The copy promises something just below the surface of the carbonation — energy, youth, the particular shimmer of a life being lived correctly. It is 1953, and the soda fountain is the wellness hub of its age. The drink is mostly water, mostly sugar, and entirely a mood sold back to you at a markup.
Now open Instagram.
The bottle has gone matte. The label is sage green, or dusty blush, or the specific off-white that signals a founder who shops at farmers' markets. The font is a self-serious serif, the kind that implies a slow, considered life. The copy reads: Adaptogenic. Functional. Botanically infused sparkling water with ashwagandha, lion's mane, and a hint of yuzu. The woman holding it is not in a sundress; she is in linen, outdoors, eyes closed as if listening to something the rest of us cannot hear. She is, unmistakably, well.
Strip away the packaging — the restraint of the palette, the medical cadence of the ingredients list, the soft authority of the lifestyle photography — and you are holding the same product the 1950s housewife was sold: expensive water, a sweetener (or its chic contemporary substitute, monk fruit), and an engineered fantasy of what your life could feel like if you simply consumed differently. The mechanism is identical. Only the aesthetics have been laundered.
This is the founding irony of the modern wellness industry: it presents itself as the antithesis of Big Food while running the same play, with better fonts and a more sophisticated understanding of its customer's anxieties.
The Core Argument
Legacy soda companies sold vitality in a bottle. They did it loudly, with primary colors and celebrity endorsements and a cultural ubiquity that made carbonated sugar water feel like participation in American life itself. The wellness industry does something subtler and, arguably, more insidious: it sells the same vitality, but frames the transaction as an act of self-knowledge. Buying a $14 adaptogenic sparkling water is not indulgence — it is optimization. It is not a treat — it is a protocol.
The vocabulary has done a great deal of work here. Where Coca-Cola promised you would feel better, the wellness industry promises to support cognitive function, modulate stress response, and promote cellular resilience. These phrases are not quite medical claims — they cannot be, legally — but they are constructed to sound like the sentence before one. They borrow the grammar of science without incurring the burden of its standards. The result is a product that occupies a strange regulatory no-man's-land: too vague to verify, too specific-sounding to dismiss, and priced at a point that implies someone, somewhere, did the research.
That someone rarely did.
The Pathologizing Engine
The deeper mechanism — the one that separates modern wellness marketing from its soda-fountain ancestor — is the pathologization of ordinary human experience. Coca-Cola never told you that you were broken. It told you that you deserved refreshment. The genius of contemporary wellness is that it has reversed the polarity: first, convince the consumer that their baseline state is a problem; then, sell them the solution.
You are not simply tired after a long week. You are experiencing adrenal dysregulation. You are not distracted; you have suboptimal dopamine architecture. You are not just thirsty; you are chronically under-mineralized, which is why your $3 tap water is failing you and why you need a $38 bottle of electrolyte concentrate with "trace Himalayan minerals." The mundane frictions of being a biological creature — fatigue, brain fog, bloating, restless sleep, fluctuating mood — have been repackaged as a syndrome, and every syndrome requires a product.
This is not wellness. This is the manufacture of insufficiency at scale.
The 1950s Coca-Cola ad created desire by projecting aspiration outward: look at the life you could be living. The modern wellness post does something more intimate and more destabilizing: it points inward, at your body, and suggests that what you find there is a problem you are perhaps not yet sophisticated enough to name. The product does not merely refresh you. It corrects you.
The Thesis
What the wellness industry has achieved — and it is, in its way, a remarkable achievement — is the rebranding of unnecessary luxury consumer goods as vital healthcare. Sleep is not something your body does automatically and for free; it is something you must biohack with magnesium glycinate stacks and blue-light-blocking glasses and a $400 weighted blanket engineered to simulate the neurological comfort of being held. Hydration is not something a glass of water accomplishes; it requires electrolyte sachets, hydrogen-infused water bottles, and an understanding of your personal sodium-to-potassium ratio. Movement is not something your body was built for and craves; it is a practice, best supported by collagen peptide powders, recovery boots, and wearable technology that tells you, with an authority that brooks no argument, that your readiness score today is a 63 and you should consider taking it easy.
In each case, the free thing — the boring, ancient, unglamorous free thing — has been surrounded by a paid ecosystem so dense and so confidently presented that the free thing becomes invisible. Sleep. Water. Movement. Food. Sunlight. These are the actual fundamentals of human well-being, and they are, with rare medical exception, available to most people at little to no cost. They do not come in matte bottles. They cannot be subscribed to. They generate no recurring revenue and require no founder story.
Which is precisely why the wellness industry cannot afford to talk about them.
By pathologizing normal human physiology and commodifying basic biology, the wellness industry has pulled off a trick that the soda companies, for all their marketing genius, never quite managed: it has convinced a significant portion of its customers that taking care of themselves is a complex, technical undertaking that requires expert guidance, premium inputs, and continuous consumption — and that to believe otherwise is to be naive about the demands of the modern body. The soda fountain sold you refreshment. The wellness industry has sold you the idea that without it, you are not quite well. That is a far more durable and profitable thing to sell.
The water is still mostly water. The sugar has simply learned a new name.
II. The Anatomy of the Rebrand: Soda vs. "Functional" Elixirs
There is a formula to this, and it is not complicated. Take a beverage — carbonated water, flavoring, a sweetener, maybe some color — and add a small quantity of something with a clinical name. Print that name on the label in a font that suggests restraint. Price it at the upper boundary of what the target demographic will absorb before asking questions. Photograph it in natural light next to something made of raw linen or unfinished wood. Post. The product is now functional. The product is now a biohack. The product is, with great discipline and consistency of brand voice, wellness.
The playbook is not new. What is new is how thoroughly the wellness industry has studied it, refined it, and stripped out the one thing that made the original version seem gauche: the honesty about what it was selling.
Rebranding the Molecule
The first move in the rebrand is sweetener laundering. High fructose corn syrup — the ingredient that became, through a convergence of scientific criticism and cultural anxiety, shorthand for everything wrong with processed food — does not appear in functional beverages. It has been replaced by a roster of alternatives that share its primary characteristic (sweetening the product) while carrying none of its baggage. Agave nectar arrives trailing associations with artisanal Mexican culture and desert botany. Monk fruit extract sounds like something a Tibetan herbalist might offer you. Dates, when used as a sweetener, conjure something almost biblical — ancient, whole, untouched by industry.
What these alternatives share, which their marketing does not foreground, is a metabolic reality that the body processes with impressive indifference to branding. Agave nectar is, by composition, between 70 and 90 percent fructose — a higher fructose concentration than the high fructose corn syrup it is positioned to replace, and one that the liver handles through identical biochemical pathways. The organ responsible for fructose metabolism does not read labels. It does not know that the agave was sourced from a small cooperative in Jalisco. It simply receives the substrate and gets to work, and the downstream effects — modest at normal consumption, problematic at excess — are functionally the same regardless of whether the sweetener arrived in a red aluminum can or a frosted glass bottle with a wax seal.
Monk fruit extract, to its credit, genuinely delivers sweetness without a caloric payload; the mogrosides responsible for its sweetness are not metabolized in the conventional sense. But monk fruit is rarely used in isolation in functional beverages. It is typically blended with erythritol or other sugar alcohols to manage cost and achieve a more familiar mouthfeel — and here the story becomes interesting again. Erythritol, long considered the gentlest of the sugar alcohols on the basis that roughly 90 percent of it is absorbed in the small intestine and excreted through urine before reaching the colon, has become the subject of more pointed research scrutiny. A 2023 study published in Nature Medicine found an association between elevated plasma erythritol levels and major adverse cardiovascular events, though the causal direction remains a matter of active scientific debate. The finding has not filtered meaningfully into functional beverage marketing. The labels still say "naturally sweetened." They still feature a small leaf.
The sweetener substitution is, in this sense, a microcosm of the whole enterprise: a genuine difference in ingredient, a negligible-to-uncertain difference in physiological outcome, and a very large difference in price and perceived virtue.
The 2mg Problem
The second move is what might be called the threshold illusion, and it is where the wellness industry's debt to the language of science becomes most legible — and most dishonest.
Ashwagandha is a legitimate subject of scientific inquiry. The adaptogen, derived from the root of Withania somnifera, has a reasonable evidence base at therapeutic doses — typically 300 to 600 milligrams of a standardized root extract — for modest reductions in perceived stress and cortisol levels. The operative word is "therapeutic." These are doses used in randomized controlled trials. These are the quantities at which the molecule does something measurable in the human body.
A standard functional sparkling water contains somewhere between 50 and 200 milligrams of ashwagandha, and often does not specify whether this refers to raw root, root extract, or a standardized KSM-66 or Sensoril extract — distinctions that matter enormously because the concentration of active withanolides varies by an order of magnitude across these forms. Lion's mane mushroom faces the same problem with greater severity: the doses in clinical studies examining its effects on nerve growth factor synthesis and mild cognitive symptoms range from 500 milligrams to three grams of dried mushroom powder daily, taken consistently over weeks. The quantity present in a wellness beverage, when disclosed at all, typically appears as part of a proprietary blend — a regulatory accommodation that means the manufacturer is not required to specify exactly how little of each ingredient is present, only that the blend as a whole contains some of each.
This is the 2mg problem, and it operates through a single psychological mechanism: the mere presence of a studied compound confers the implied endorsement of the science around that compound, regardless of whether the dose is anywhere near what the science actually studied. Consumers do not read the clinical literature on ashwagandha. They read the word "ashwagandha" on a label and complete the association themselves, having absorbed, through the general cultural atmosphere of wellness content, that ashwagandha is a thing that serious, optimized people take for stress. The beverage has harvested the science's credibility without delivering its substance.
The price premium this generates is remarkable in its audacity. A can of Kin Euphorics Lightwave retails for around $6. Its active ingredient list includes GABA, 5-HTP, and L-theanine alongside various adaptogens — compounds that exist in a state of genuine scientific interest but whose oral bioavailability, dosage, and interaction effects in combination are far from settled. GABA in particular presents an immediate pharmacological problem: orally consumed GABA does not cross the blood-brain barrier in meaningful quantities in most adults, which means that a functional beverage advertising GABA for relaxation is, at the mechanistic level, advertising a molecule that cannot reliably reach the organ whose function it is claimed to support. This is not a fringe position. It is the current scientific consensus, repeated in neuropharmacology literature with the mild exasperation of researchers who have been making this point for years. The label does not mention it.
The Marketing Pivot: From Happiness to Anxiety
The third move — and the one that marks the true departure from the legacy soda playbook — is the emotional repositioning of the product's promise.
Coca-Cola sold happiness. This was not subtle; it was the explicit, long-running claim, rendered in the visual language of crowds and parties and sunlit afternoons and the almost aggressive social belonging of the shared bottle. The emotional proposition was addition: drink this and you will have more — more joy, more energy, more connection. The baseline was assumed to be fine. The product would make it better.
The modern functional beverage does not sell addition. It sells correction — though it has learned to dress correction in the language of optimization so that it does not feel like a diagnosis. Kin Euphorics, one of the more sophisticated operators in this space, markets its products explicitly as alcohol alternatives for people who are "rewriting the rules of social drinking" — a positioning that simultaneously flatters the consumer's identity (you are the kind of person who questions default cultural scripts), addresses a genuine and growing behavioral trend (sober-curiosity has real demographic traction, particularly among younger adults), and creates anxiety about the default. If you need to "rewrite the rules," the rules were presumably doing you some damage. Kin does not say this directly. It does not need to.
Poppi, a prebiotic soda that achieved remarkable market penetration before its acquisition by PepsiCo in 2025, built its brand on the gut microbiome — a genuinely fascinating and incompletely understood area of research that has become, in wellness marketing, something close to a universal solvent. The gut microbiome can be invoked to explain mood, immunity, cognitive function, skin health, and metabolic outcomes, which makes it extraordinarily useful as a marketing anchor because the science is real enough to cite, complex enough that consumers cannot easily evaluate the specific claims, and diffuse enough that almost any product can gesture at it plausibly. Poppi contains apple cider vinegar and inulin, both of which have modest evidence bases at doses higher than those present in a single can. What it has in abundance is the microbiome's cultural authority, packaged in cans so visually arresting that they generate organic social content simply by existing near a countertop.
Liquid Death operates at a different register of cynicism and is, in its way, the most honest product in this analysis — it is aggressively aware of its own absurdity. The brand sells canned water in packaging that references heavy metal iconography with the tagline "Murder Your Thirst," charges a meaningful premium for the experience of treating hydration as an aesthetic identity, and has built a substantial business doing so. There is no therapeutic claim. There is no adaptogen. There is only the proposition that the kind of person you are is expressed through the water you drink, and that the specific kind of person Liquid Death speaks to is one who finds both the corporate cheerfulness of Coca-Cola and the hushed earnestness of the wellness aisle equally insufficient. It has simply found a different anxiety to address: the anxiety of being seen consuming something basic.
Together, these brands represent a complete map of the emotional territory the modern functional beverage market has staked out. Kin sells anxiety about your nervous system. Poppi sells anxiety about your gut. Liquid Death sells anxiety about your personality. None of them sell what Coca-Cola sold, which was, for all its cynicism, the comparatively benign promise that you might simply feel good.
The market has matured. Feeling good is no longer sufficient. Now you must be optimized, aligned, legible as a specific kind of person, and sufficiently concerned about the correct aspects of your own biology. The beverage is the proof of all of this. At $6 to $9 a can, it had better be.
III. Exposing the Three Big Pillars of Wellness Pseudoscience
Before the pillars, a structural note. The wellness industry does not operate through outright fabrication — that would be legally risky and, more importantly, unnecessary. It operates through a more elegant mechanism: taking real science, real biology, and real physiological processes, and then extrapolating from them at a distance so great that the destination bears only a formal resemblance to the departure point. The liver does detoxify. Nutrients do matter. Sleep and metabolic health are genuinely connected. None of this is false. What is false — or rather, what is carefully constructed to feel true without being demonstrably so — is the conclusion that a $90 monthly powder subscription or a $4,000 infrared sauna is the appropriate clinical response to these facts.
This is the architecture. Now the pillars.
Pillar 1: The Detox Delusion
The word "toxin" is doing extraordinary work in the wellness economy, and the first thing worth establishing is that it is not doing this work anywhere in the clinical literature. Search PubMed for "toxin detox cleanse." You will find studies on actual toxicological exposure — heavy metal poisoning, drug overdose, occupational chemical exposure — treated by actual medical intervention in actual clinical settings. You will not find a randomized controlled trial on the efficacy of a three-day green juice protocol for reducing undefined systemic toxic burden, because no serious researcher has proposed such a trial, because the premise does not survive contact with basic physiology.
The human body runs a detoxification system of a sophistication that no $65 "21-Day Reset" program has come close to replicating, and it runs this system continuously, without a subscription, without a morning ritual, and without activated charcoal. The liver alone performs over 500 distinct metabolic functions, among them Phase I and Phase II detoxification: a two-stage enzymatic process in which cytochrome P450 enzymes first oxidize fat-soluble compounds into intermediate metabolites (Phase I), which are then conjugated — bound to water-soluble molecules like glucuronic acid, sulfate, or glutathione — to facilitate their excretion through bile or urine (Phase II). This is not a metaphor. It is biochemistry that happens in your hepatocytes right now, while you read this, regardless of whether you had a green juice this morning.
The kidneys filter approximately 180 liters of blood per day, selectively reabsorbing what the body needs and excreting the rest through urine. The lungs exchange gases across a surface area of roughly 70 square meters. The gastrointestinal tract maintains a mucosal barrier that manages the selective absorption of nutrients while excluding pathogens and undigested compounds, and the skin — occasionally claimed by wellness brands as a "detox organ," usually in the context of selling something sweating-adjacent — does excrete small quantities of certain compounds, though its primary function is barrier protection rather than excretion.
This system fails in the context of serious disease — hepatic failure, renal failure, sepsis — and when it fails, the intervention is not a juice cleanse. It is dialysis, or a liver transplant, or intensive pharmacological support. The notion that this same system, functioning normally in a healthy person, requires periodic consumer-product-assisted "flushing" rests on no physiological mechanism that has been identified, described, or demonstrated in peer-reviewed literature. The brands selling cleanses know this, or they would be able to specify which toxins their product removes and by what pathway. They do not specify, because the regulatory consequences of a specific claim are severe, and because vagueness is more durable than precision. "Toxin" remains undefined because the moment it is defined, it can be tested. The grift requires the fog.
What detox products actually deliver is worth examining on its own terms, because it is not nothing — it is just not what is advertised. A juice cleanse is, in metabolic terms, a period of severe caloric restriction accompanied by high sugar intake from fruit, which produces a rapid glycemic response followed by the subjective experience of feeling lighter, clearer, and more virtuous that accompanies any abrupt change in dietary pattern. Some of this is physiological: the absence of processed food, alcohol, and excess sodium reduces water retention and inflammatory load. Some of it is psychological: structured eating with a defined endpoint produces a sense of control that has real mood effects. None of it requires the cleanse to be the mechanism. It requires only that you temporarily ate less and drank more water.
Activated charcoal presents a more specific problem. Activated charcoal does bind compounds in the gut — this is why it is used in emergency medicine for acute poisoning, in carefully calibrated doses, within a narrow time window after ingestion, under medical supervision. In a wellness beverage, it binds indiscriminately, including binding medications, which is a clinical interaction serious enough that pharmacists warn patients about it explicitly. It also binds nutrients. The charcoal latte, in this sense, is not merely ineffective as a detox vehicle. It is, depending on what else is in your system, potentially counterproductive.
Senna-based detox teas operate through a simpler mechanism: they are stimulant laxatives. Sennosides, the active compounds, stimulate peristalsis in the colon, producing the rapid intestinal evacuation that many consumers interpret as evidence that something toxic has been "flushed." What has been flushed is water and stool. The scale registers a lower number. The cleanse appears to have worked. Chronic use of stimulant laxatives — a pattern the 30-day "detox tea" subscription actively encourages — disrupts the enteric nervous system's normal motility function, potentially producing a dependency on stimulant laxation to achieve normal bowel movements. The product that promised to clean you out can, with consistent use, make it harder for your body to do so on its own.
This is the detox grift at its most precise: selling a solution to a problem the body does not have, with a product that, in some cases, creates the conditions for the problem it claimed to solve.
Pillar 2: Miracle Powders and the Myth of the Nutritional Safety Net
AG1 — formerly Athletic Greens, rebranded with the kind of alphanumeric minimalism that signals premium positioning — retails at approximately $79 to $99 per month for a daily single-scoop serving. Its marketing proposition is elegant and anxiety-exploiting in equal measure: the modern diet is insufficient, supplementation is complex and confusing, and AG1 is the single comprehensive solution that replaces the entire supplement shelf. One scoop. Done. Optimized.
The ingredient list is impressive in its ambition. Seventy-five vitamins, minerals, and whole-food-sourced ingredients, including a proprietary blend of greens, a probiotic blend, an adaptogen blend, and an antioxidant blend. The label is a document that confers authority through density alone. Most consumers do not read it in full. Those who do encounter the same problem as the functional beverage consumer from the previous section: proprietary blends do not disclose individual ingredient quantities, so there is no way to evaluate whether any given component is present at a dose that corresponds to the evidence base for that ingredient. The blends exist, legally and functionally, to make the formula impressive to read and impossible to scrutinize.
The deeper issue is bioavailability, and it is one the powder supplement industry has never satisfactorily resolved. The human body has evolved to extract nutrients from a food matrix — a complex structural environment in which proteins, fats, fibers, and phytonutrients exist in physical and chemical relationships with one another that influence absorption. The carotenoid lycopene is absorbed significantly better from cooked tomato products than from raw tomatoes, because the cooking process disrupts the plant cell wall and the presence of fat in the meal further facilitates absorption. Glucosinolates in cruciferous vegetables are converted to their active isothiocyanate forms partly through the action of myrosinase, an enzyme present in the plant that is activated by chopping or chewing — a process that has no analog in the manufacture of a dehydrated greens powder, which applies heat that denatures myrosinase before any conversion occurs. Iron from plant sources is absorbed at dramatically lower rates than heme iron from animal sources, and its absorption is further modified by the presence of vitamin C, phytates, calcium, and polyphenols in the meal — a set of interactions that a powder dissolving in water cannot replicate.
This is not an argument that powders have zero utility in every context. Vitamin D supplementation is supported by robust evidence, particularly in populations with limited sun exposure. Folate supplementation in pregnancy has an unambiguous evidence base and is universally recommended. The point is not that supplements are categorically useless. The point is that a dehydrated greens powder is not a nutritional equivalent to eating vegetables, and the marketing that implies otherwise — the language of "foundational nutrition" and "filling the gaps" — is exploiting a genuine public anxiety about dietary adequacy to sell a product whose efficacy at the doses delivered, and in the form delivered, is considerably less established than the price suggests.
The concept of "expensive pee" is inelegant but physiologically accurate. Water-soluble vitamins — the B vitamins and vitamin C — are not stored in meaningful quantities. Once cellular needs are met, the excess is filtered by the kidneys and excreted in urine. The body's capacity to absorb and utilize vitamin C, for instance, is subject to saturation kinetics: at doses of 200 milligrams, absorption is approximately 100 percent. At 1,250 milligrams, it drops to around 33 percent, and the unabsorbed remainder passes into the colon, where large quantities can cause osmotic diarrhea. A daily greens powder that delivers 700 percent of the RDA for vitamin C is not delivering 700 percent of the benefit. It is delivering, past the saturation point, a progressively more expensive and progressively less utilized nutrient that exits through the urinary tract.
Collagen powders deserve their own paragraph, because they are perhaps the most successful supplement in recent years and operate on a premise that is genuinely interesting from a biochemical standpoint — and also genuinely misleading. Collagen is the most abundant protein in the human body, providing structural integrity to skin, tendons, ligaments, and bone. Its degradation is associated with aging skin and joint deterioration, and this is real. The supplement industry's inference from this fact — that consuming collagen will replenish the body's collagen — does not follow from it. Ingested collagen is a protein, and like all dietary proteins it is digested into its constituent amino acids before absorption. These amino acids — primarily glycine, proline, and hydroxyproline — enter the general amino acid pool and are used by the body according to its current priorities, which are not necessarily the reconstruction of skin collagen. The body does not route the glycine from your morning collagen latte specifically to your dermis. Some studies show modest improvements in skin elasticity and joint comfort at doses of 2.5 to 10 grams of hydrolyzed collagen peptides daily, and the mechanistic explanation currently favored involves the bioactive peptides surviving partial digestion and stimulating fibroblast activity — a plausible but not fully established pathway. The effect sizes are small. The studies are frequently funded by collagen manufacturers. The marketing is not small.
Pillar 3: The Influencer Biohack Trap
The biohacker presents as the most rigorous figure in the wellness ecosystem — the one who has moved beyond marketing claims into the realm of data, self-experimentation, and peer-reviewed literature. This self-presentation is important to examine, because it is precisely what makes the biohack influencer the most effective vector for the industry's most expensive and least substantiated products. The aesthetic is lab coat rather than linen. The props are continuous glucose monitors and HRV data and VO2 max readouts rather than botanical illustrations. The language is mechanistic, specific, and confidently delivered. It has all the grammar of science without always having the content.
Science-washing operates differently from ordinary wellness marketing. It does not rely on the mere presence of a studied ingredient name. It relies on the citation — the actual invocation of research, typically delivered in the cadence of a podcast or a long-form YouTube video, with the name of a journal, an author, a study. The audience, exposed to what feels like a rigorous evidential standard, extends the study's credibility to the product recommendation that follows. What is rarely examined is the distance between the study and the recommendation.
Mouse models are the foundational substrate of biohack science-washing. Mice are useful research organisms for many purposes, and the early-stage research conducted in rodent models is a legitimate and necessary part of the scientific pipeline. What the pipeline requires, for translation to human clinical recommendation, is replication in human trials — ideally large, randomized, controlled, and conducted by researchers without a financial relationship to the outcome. The biohack influencer frequently short-circuits this pipeline. A mouse study demonstrating that rapamycin extends median lifespan in inbred laboratory mice under controlled conditions becomes, in the influencer's hands, evidence for a human supplementation protocol. A small-sample-size human pilot study — ten or twenty or forty participants, no control group, self-reported outcomes, funded by the supplement company — becomes "the science." The epistemological standards are selectively applied: rigorous citation when the study supports the protocol, conspicuous silence when the replication fails or the effect disappears in a larger trial.
The continuous glucose monitor worn by people without diabetes is an instructive case study in this dynamic. CGMs are genuinely transformative medical technology for people managing diabetes or prediabetes, providing real-time glucose data that enables meaningful clinical decision-making. In the biohacker context, they are deployed in metabolically healthy individuals to generate data about postprandial glucose spikes — the normal, transient rise in blood glucose that follows carbohydrate consumption — and to interpret these spikes as evidence of metabolic dysfunction requiring intervention. The physiology does not support this interpretation. A postprandial glucose rise to 140 mg/dL in a healthy person, returning to baseline within two hours, is the normal operation of an intact incretin response and functioning pancreatic beta cells. The spike is not the problem. The failure to return to baseline is the problem, and in metabolically healthy individuals, this failure does not occur. The CGM, in this context, does not provide actionable clinical information. It provides the experience of data — the quantified self, watching itself — and generates anxiety about normal biological processes that then requires, conveniently, a protocol to address.
That protocol typically involves a combination of further purchases and behavioral constraints. Infrared saunas, available as personal units at prices ranging from $1,500 to over $10,000, are promoted through the genuine literature on heat shock proteins — molecular chaperones activated by thermal stress, involved in cellular repair processes — and through observational studies from Finland demonstrating associations between sauna frequency and reduced cardiovascular mortality. The Finnish studies are real and interesting. They are also observational, conducted in a population for whom sauna is a deeply embedded cultural practice accompanied by specific social behaviors, and they cannot be disentangled from the broader lifestyle context in which they occur. Heat stress does activate heat shock proteins; the clinical significance of this activation in the context of a 45-minute home sauna session three times a week in a person who also has access to exercise, adequate sleep, and a reasonable diet is not established. The mechanism is real. The translation is a leap.
Hyperbaric oxygen therapy — pressurized chambers delivering 100 percent oxygen, originally developed for decompression sickness and wound healing in diabetics — has been recruited into the biohack protocol at personal unit prices between $4,000 and $20,000 for mild-pressure consumer versions. The clinical literature on HBOT is legitimate for its approved indications. For healthy longevity optimization, the evidence is thin, the long-term safety data at repeated exposure in healthy individuals is limited, and at least one case series has documented oxygen toxicity-related seizures associated with home use. The FDA has explicitly warned against off-label HBOT for autism, cancer, and a range of other conditions marketed by wellness providers. These warnings appear in regulatory documents. They do not appear in influencer content.
What the biohack ecosystem produces, at its far end, is not optimized biology. It is a clinical-grade anxiety disorder organized around health — what eating disorder researchers and clinical psychologists increasingly describe using the term orthorexia nervosa, a pathological preoccupation with dietary purity and health optimization that, in its severe forms, produces the restriction, social isolation, and physiological consequences it was designed to prevent. The irony is structural. The industry that sells anxiety relief as its core product requires, for its continued operation, the maintenance of anxiety. The CGM must always find a spike. The HRV score must always have room for improvement. The readiness score must hover just below perfect. The protocol must always require refinement, because a person who feels genuinely well is a person who has stopped shopping.
Longevity is not a subscription service. The most robust data on human lifespan and healthspan — from the Blue Zone research, from decades of epidemiological study, from the long-running Nurses' Health Study and the Framingham Heart Study — converges on a set of exposures so mundane that no influencer could build a content strategy around them. Regular moderate movement. Social connection. Adequate and consistent sleep. A diet with abundant plants, limited ultra-processed food, and no particular requirement for supplementation in the absence of deficiency. A sense of purpose. The absence of chronic psychological stress, which is worth noting, is not addressed by purchasing the tools that generate chronic physiological anxiety about your own metrics.
None of this is new. None of it is proprietary. None of it ships in a matte box with a personalized welcome card.
Which is, of course, precisely the problem.
IV. The Cost of Distraction: Ignoring the Boring Fundamentals
There is a psychological phenomenon in behavioral economics called moral licensing, and it is doing quiet, expensive damage to the health of people who believe they are taking their health seriously. The mechanism: when a person performs an action they associate with virtue, they subsequently grant themselves implicit permission to behave in ways that undermine that virtue. The person who exercises in the morning orders the larger meal at lunch. The person who recycles feels entitled to fly more freely. The person who spends $200 a month on a wellness stack — the greens powder, the adaptogenic sparkling water, the collagen creamer, the probiotic capsule — has performed, every morning, a ritual of health that the rest of the day does not need to match quite so carefully.
This is not a character flaw. It is a predictable output of the way human cognition manages effort and reward. What makes it medically relevant is the specific things the wellness ritual is licensing people to not do, and the size of the gap between the physiological value of what is purchased and the physiological value of what is displaced.
The Illusion of Control and What It Costs
The wellness industry sells control in a period when the perception of control over one's own body is unusually fragile. Chronic disease is rising. Longevity research is generating headlines that simultaneously promise dramatic life extension and remind people of every lifestyle factor that might be quietly shortening theirs. The food system is genuinely difficult to navigate. The information environment around health is so densely contradictory that the rational response, for many people, is to find a trusted authority — a brand, an influencer, a protocol — and outsource the complexity. The $90 greens powder does not merely sell nutrients. It sells the feeling of having handled it. Of having, each morning, done the thing. The rest is detail.
What the research on health behavior calls the displacement effect describes something more concrete: the adoption of a visible, low-friction health behavior that substitutes for a higher-friction, higher-impact one. The supplement becomes a functional replacement not for nutrient deficiency but for the cognitive and behavioral load of actually eating better. The detox tea substitutes for addressing the dietary pattern that felt like it required detoxing. The infrared sauna becomes the recovery protocol that makes it easier to justify not sleeping enough, because recovery is being handled, actively, through a technology you purchased. The tools do not merely fail to deliver their promised benefits. They provide enough of a sense of accomplishment that the behaviors most correlated with those benefits — the ones that require sustained effort, social negotiation, and the tolerance of difficulty — become easier to defer.
A 2021 study in the Journal of Consumer Research found that people who purchased health-signaling products subsequently demonstrated reduced commitment to health-promoting behaviors compared to a control group, an effect the researchers termed "health licensing." The product had done the work, perceptually, of being healthy. The body, operating on physiology rather than perception, registered none of this.
The Free, Unmarketable Fundamentals
What the body actually requires for sustained health is known. It has been known, in its broad outlines, for long enough that the continued existence of an industry selling expensive alternatives to it represents a remarkable cultural achievement. The fundamentals are not secret. They are not complex. They are not, in any meaningful sense, insufficient. They are simply boring, and in the attention economy, boring is functionally invisible.
Sleep is where the displacement effect causes the most measurable physiological harm, partly because it is where the wellness industry's intervention is most counterproductive. Sleep is the body's primary endogenous restoration system — the period during which adenosine clears from the brain, glymphatic flow removes metabolic waste products including amyloid-beta and tau proteins associated with neurodegeneration, cortisol resets to its circadian nadir, and the hippocampus consolidates declarative memory through slow-wave activity. None of this is metaphorical. The glymphatic system — the brain's waste clearance pathway, which operates primarily during slow-wave sleep and is driven by cerebrospinal fluid pulsing through channels alongside cerebral blood vessels — was not identified until 2012, and its disruption by sleep insufficiency has become one of the more compelling mechanistic explanations for the association between chronic poor sleep and elevated Alzheimer's risk.
Seven to nine hours of sleep for most adults is not a recommendation derived from convention. It is derived from decades of experimental sleep restriction studies, epidemiological data, and, increasingly, mechanistic research on what the sleeping brain is doing and what it fails to do when the window is shortened. Matthew Walker's laboratory at UC Berkeley, among others, has demonstrated that a single night of sleep deprivation to six hours produces a 70 percent reduction in the activity of natural killer cells — a primary immune defense against malignant cells — a finding that puts the immune-support marketing of most supplement products in sharp, unflattering relief. No greens powder has produced a comparable effect size in an immune biomarker in a human trial. The comparison is not reasonable. It is, nonetheless, real.
The wellness industry's relationship with sleep is complicated by the fact that it recognizes sleep's importance — sleep is on-brand, sleep is science-adjacent, sleep is talked about approvingly in every longevity podcast — while simultaneously offering products that interfere with it. Caffeine, present in most "energy-supporting" functional products, has a half-life of five to six hours and a quarter-life of ten to twelve, meaning that a matcha latte with "clean energy" consumed at 2 PM still has a quarter of its caffeine load in circulation at midnight. Magnesium glycinate, lion's mane, and ashwagandha are all marketed partly on sleep-quality claims, generating a situation in which the solution to the sleep problem created by the morning stimulant product is the evening relaxation product. The industry has successfully sold both ends of the disruption it partly causes.
Water requires less elaboration but deserves its moment, because the gap between what is sold and what is needed is here at its most absurd. The body requires approximately 2.5 to 3.5 liters of fluid daily under normal conditions, a figure that varies with body size, temperature, and activity. Municipal tap water in most developed countries is among the most rigorously tested and regulated food products that exist — in the United States, the EPA's primary drinking water regulations cover over 90 contaminants with enforceable maximum contaminant levels, and municipal systems are required to publish annual consumer confidence reports detailing what is and is not in the water supply. This water is available at a cost of approximately one one-hundredth of a cent per liter in most American cities.
The market for premium water — hydrogen-infused, mineral-balanced, pH-optimized, glacier-sourced, structured (a term with no agreed physical definition and no demonstrated physiological effect) — is valued at billions of dollars and growing. Hydrogen water, among the more aggressively marketed variants, deserves specific attention: the claim rests on hydrogen's role as an antioxidant capable of selectively neutralizing hydroxyl radicals. The primary physiological obstacle is that molecular hydrogen gas is extremely poorly soluble in water at atmospheric pressure, meaning that a hydrogen-infused beverage opened at room temperature begins outgassing its hydrogen content immediately, and the quantity that reaches the bloodstream through intestinal absorption is, in the current literature, insufficient to produce the antioxidant effects demonstrated in the studies typically cited in its marketing. Those studies, when they exist in human subjects rather than cell culture, tend to involve hydrogen administered through inhalation or hydrogen-rich saline injection — delivery methods that bear no resemblance to drinking a can of sparkling water with a small dissolved hydrogen payload.
The tap is fine. The tap has always been fine.
Walking outside in daylight is a compound intervention that no product currently available can replicate, and the failure to market it successfully represents the wellness industry's most revealing limitation. Twenty to thirty minutes of outdoor walking in daylight delivers: bright-light exposure to the retina in the first half of the day, which entrains the suprachiasmatic nucleus — the brain's master circadian clock — and delays the onset of melatonin secretion to the appropriate evening window; low-to-moderate intensity physical activity that improves insulin sensitivity, reduces resting cortisol, supports cardiovascular function, and generates BDNF (brain-derived neurotrophic factor), a protein critical to hippocampal neurogenesis and mood regulation; exposure to natural environments, which produces measurable reductions in prefrontal cortex rumination as demonstrated in studies measuring neural activity in the subgenual prefrontal cortex before and after nature walks; and, frequently, the social contact that occurs incidentally when a person is outside and moving through a shared environment.
The pharmacological profile of this intervention, if it arrived in a bottle, would represent a blockbuster product. It is free, available universally, requires no supply chain, and produces no side effects in the overwhelming majority of the population. It does not have a founder. It cannot be subscribed to. It generates no recurring revenue and no user data. It has, accordingly, received a fraction of the marketing spend of a mid-tier supplement brand.
Dietary fiber is perhaps the most under-consumed nutrient in the Western diet with the most robust evidence base behind it, which makes the relative absence of "fiber" from the functional food marketing conversation instructive. Average American fiber intake sits around 15 grams daily against a recommended 25 to 38 grams — a gap with documented consequences for gut microbiome diversity, colorectal cancer risk, cardiovascular outcomes, and glycemic regulation. Fiber is also, in the forms most accessible to most people — beans, lentils, whole grains, vegetables, fruit — extremely inexpensive. A daily cup of cooked lentils delivers roughly 16 grams of fiber, complete protein, iron, folate, and a prebiotic substrate for the gut microbiome that is more structurally complex and ecologically useful than any encapsulated prebiotic blend currently on the market. It costs, depending on your market, between 20 and 40 cents.
The prebiotic supplement market is projected to reach $12 billion by 2030. Lentils remain priced as a poverty food.
Social connection is the fundamental that the wellness industry has proven most incapable of commodifying — though not for lack of trying. The evidence on social isolation and health is among the most consistent in epidemiology: chronic loneliness is associated with elevated inflammatory markers, dysregulated cortisol rhythms, impaired immune function, accelerated cognitive decline, and a mortality risk that several meta-analyses have estimated as comparable to smoking 15 cigarettes a day. The mechanism is not metaphorical. Social threat activates the same inflammatory pathways as physical injury — the brain does not cleanly distinguish between social pain and physical pain, a finding with implications for the low-grade chronic stress that loneliness generates and the inflammatory load that stress sustains.
The wellness industry sells community — in the form of brand apps, subscription cohort programs, and the parasocial relationship between influencer and follower — while the products it sells are consumed alone, in the kitchen, in the morning, before anyone else is awake, as a private ritual of optimization. The community is the marketing. The consumption is solitary.
Why the Fundamentals Stay Invisible
The cynical answer is venture capital, and it is mostly correct. The behavioral fundamentals of human health — sleep, movement, water, whole food, connection — cannot be enclosed. They cannot be made proprietary. They cannot be put behind a subscription paywall or improved through a Series B funding round. There is no moat, in the business strategy sense, around telling someone to go to bed at a consistent time. A company that built its value proposition on that advice would have no defensible market position and would be copied immediately by every competitor.
The wellness industry requires, at an existential level, that the free things be insufficient. Not dangerous — insufficient. The message is never that sleep is bad. It is that sleep, alone, is not enough. That your sleep needs to be optimized, tracked, supplemented, and supported by a mattress with temperature regulation and a wearable that scores its quality. That your vegetables need to be augmented by the compounds that vegetables contain but that your vegetables, specifically, may not be delivering in optimal bioavailable form. That your walk needs to be tracked, and your steps counted, and your heart rate zone monitored, and your route varied to stimulate novelty-seeking neural circuitry, and your recovery from the walk supported by electrolytes and protein. The fundamentals are acknowledged and then immediately surrounded by a paid ecosystem so dense that navigating back to the unenclosed original becomes psychologically difficult. You can see the thing. You just can't quite get to it without passing through the store.
There is no venture capital money in an apple. There is no IP in eight hours of sleep. There is no influencer content in drinking a glass of water, walking outside, calling a friend, and going to bed when you are tired — unless you are also wearing four tracking devices and consuming three sponsored supplements while doing it, in which case there is quite a lot of content, actually, and several affiliate codes.
This is not a conspiracy. It is a market. Markets go where the margins are, and the margins are not in the boring things. The boring things are already there, already working, already free, and they have the considerable disadvantage, from a commercial standpoint, of not requiring you to buy them again next month.
The body does not care about this problem. It continues to ask, with the blunt biological persistence it has always had, for the same things it has always needed. It asks through fatigue and hunger and the pull toward sunlight and the specific relief of genuine rest. It does not ask through cravings for ashwagandha. It does not experience a deficit that collagen powder corrects. It is not waiting for the biohack.
It is waiting for you to go to sleep.
Conclusion: The Radical Act of Being Boring
At some point in the last decade, taking care of yourself became a consumer identity, and that shift — quiet, incremental, dressed in the language of empowerment — is worth sitting with for a moment before accepting it as natural. It is not natural. It is engineered.
The modern wellness industry did not create human anxiety about health and mortality. It did not invent the desire to feel better, live longer, or exert some meaningful agency over a body that will, despite all efforts, eventually fail. These are ancient preoccupations, and they are legitimate ones. What the industry did — with considerable creativity, genuine marketing sophistication, and the structural advantages of a regulatory environment that permits health-adjacent claims it cannot be compelled to substantiate — was locate those preoccupations and build a toll road through them. You may pass. You may pursue health. But the journey now has a gift shop, and the gift shop is enormous, and it has been designed by people who understand, at a granular level, that the most profitable anxiety is one that is never fully resolved.
The soda comparison that opened this article is not rhetorical convenience. It is the actual history. The processed food industry spent the latter half of the twentieth century engineering hyperpalatable products that displaced whole foods, pathologized cooking as an inconvenient time burden, and positioned their own solutions — convenient, branded, shelf-stable — as the modern answer to the problem their products had helped create. The wellness industry has run the same play at a higher price point and with better demographic targeting. The customer is now educated, health-conscious, and suspicious of Big Food — which makes them, paradoxically, more susceptible to a product that flatters that suspicion while replicating the underlying mechanism. You are not like the people who drank soda. You drink adaptogens. The margin on your credulity is simply larger.
What the Science Actually Says
Strip away the branding, the proprietary blends, the before-and-after testimonials, and the podcast sponsorships, and the peer-reviewed literature converges on a picture of human health that is almost offensively simple. The Nurses' Health Study, running since 1976 and encompassing over 280,000 participants across its iterations, identified the primary modifiable determinants of chronic disease risk as: not smoking, maintaining a healthy body weight, regular physical activity, a diet high in whole foods and low in ultra-processed food, and moderate or no alcohol consumption. The Framingham Heart Study, the longest-running cardiovascular cohort in existence, tells a broadly similar story. The Blue Zone research — examining the lifestyle patterns of populations with exceptional longevity across five geographically and culturally distinct regions — found that the common factors were movement embedded in daily life rather than structured exercise, plant-predominant diets, strong social bonds, a sense of purpose, and adequate rest. Not one of these studies, across their collective centuries of follow-up data, identified a greens powder, an adaptogenic beverage, or a continuous glucose monitor as a variable of interest.
This does not mean that medicine has nothing to offer beyond lifestyle. It means that for the vast majority of people without specific clinical deficiencies or diagnosed conditions, the biological return on investment available from the free fundamentals is so large, and the marginal return from premium wellness products so small, that the rational allocation of attention and resources is not a close call. The industry has successfully made it feel like a close call. That is its primary product.
The Deeper Harm
The financial cost of the wellness industry's misdirection is real — Americans spend over $60 billion annually on dietary supplements alone, much of it with limited clinical justification — but it is not the deepest cost. The deepest cost is attentional. Every hour spent optimizing a sleep supplement stack is an hour not spent addressing the 11 PM screen exposure that is actually disrupting sleep architecture. Every morning ritual built around a $90 powder is a morning ritual that has not been built around cooking a real breakfast. Every anxiety-hour logged on a health tracking app watching glucose fluctuations that are within normal physiological range is an anxiety-hour that could have been, with considerably more benefit to the person experiencing it, spent outside, or in conversation, or simply resting.
The wellness industry has medicated health anxiety with products that, in many cases, sustain the anxiety they claim to treat. You are always one supplement away from optimization. You are always one protocol from getting your readiness score above 85. The goal recedes as you approach it, because a person who has arrived at the goal is a person who has stopped spending, and the architecture of the industry cannot survive that outcome at scale.
There is also a justice dimension that commentary on the wellness industry consistently underweights. The products discussed throughout this article are priced for a specific economic stratum — one with disposable income, proximity to boutique grocery channels, and enough time and cultural capital to engage with the vocabulary of functional nutrition and biohacking. The communities with the highest burden of preventable chronic disease are not the communities purchasing AG1. They are communities where the free fundamentals are systematically harder to access — where safe outdoor space for walking is scarce, where fresh whole food is expensive relative to income, where working multiple jobs makes consistent sleep a structural impossibility rather than an optimization problem. The wellness industry does not address this. It cannot; its entire commercial logic depends on selling solutions to people with money for problems that often have structural causes. The gap between who the industry serves and who carries the greatest health burden is not a bug. It is the shape of the market.
The Radical Act
What is left, after the critique, is not nihilism about health. The physiological facts are, in their way, deeply encouraging. The most powerful interventions available to most people are already in their possession and require no shipping, no subscription, and no proprietary blend. The body is not broken in the ways the industry needs it to be broken. It is asking for things that are old and free and require sustained, undramatic attention rather than consumer enthusiasm.
Sleep until you have slept enough, consistently, for enough consecutive nights that the debt clears and you remember what rested feels like. Drink the tap water. Walk outside before the day has fully accelerated, while the light is still horizontal and the dopamine system is calibrating for the hours ahead. Eat the vegetables — not the powder made from them, not the capsule that claims to contain their active compounds, but the actual fibrous whole thing that your digestive system evolved over millions of years to process and that your gut microbiome has been waiting, specifically, for. Call someone you care about and do not optimize the conversation. Go to bed before you are exhausted.
These instructions are unglamorous. They will not generate content. They do not have a celebrity co-sign or a Series C valuation or a proprietary delivery mechanism that increases bioavailability. They are, in every sense that the attention economy uses to assign value, worthless.
In every sense that your body uses to assign value, they are nearly everything.
The wellness industry has built a remarkable business on the distance between those two valuations. Closing that distance — or even just becoming conscious of it — is not a consumer choice. It is, at this particular cultural moment, something closer to a political one. You are not a biological substrate in need of optimization. You are an animal with known needs, most of which are already met by a world that existed before anyone thought to put it in a subscription box.
The most subversive thing you can do for your health is also the most boring.
Do the boring thing.






















